MonsterIs what this company is going to be... What Aurora needs is the ability to fufil supply deals. They're damn near cornering the pharmacutical side of the business with this aquisition. The amount of patients they have aquired now with the Cannimed deal and now Medreleaf is huge. Sure, this stock may dilute, but if you've got patience, you'll be rewarded. Huge aquisition, and great for the sector. Cheers.